Novartis
- @ Apologies for the delay in responding. Thanks for your understanding7:39 AM Nov 7th from Seesmic in reply to VinumVine
- @ Thx for your Q. For H1N1 vac., Novartis on track for US delivery Seasonal flu delivered 7:38 AM Nov 7th from Seesmic in reply to VinumVine
- Celtura approval is key step toward replacing 50 year-old egg-based flu vaccine production w/ modern biotechnology 1:00 AM Nov 5th from Seesmic
- Clinical trials in more than 1850 individuals across all age groups show strong efficacy for Celtura 11:54 PM Nov 4th from Seesmic
- Novartis receives German regulatory approval for Celtura®, 1st adjuvanted cell culture-based A(H1N1) flu vaccine 10:34 PM Nov 4th from Seesmic
- Novartis opens $250M advanced technical R&D & manuf. facility in Changshu, furthering economic dev. of Jiangsu province 12:38 PM Nov 3rd from web
- Novartis Institute of BioMedical Research in Shanghai to research new meds to treat highly prevalent diseases in China 7:19 AM Nov 3rd from Seesmic
- Novartis to invest $1Bio to build largest pharmaceutical R&D institute in China 6:47 AM Nov 3rd from Seesmic
- Novartis is proud to be ranked one of the top 50 "world's most attractive employers." 8:41 AM Oct 30th from web
- New Novartis biological therapy approved in EU to treat patients with CAPS, a rare auto-inflammatory disease 11:42 PM Oct 27th from mobile web
- Novartis thanks the readers of MedAdNews for naming us "most admired pharmaceutical company" 9:21 AM Oct 23rd from web
- Novartis receives approval in EU for new 3-in-1 once-daily single pill to treat patients with high blood pressure 10:32 PM Oct 22nd from web
- Q3 Analyst webcast (slides/audio) starting now. Follow it here: 5:02 AM Oct 22nd from web
- Novartis delivers strong new product momentum and operational performance in first 9 mos. of 2009 10:13 PM Oct 21st from web
- We will announce our Q3 results tomorrow, Oct 22. Analyst webcast starts 2pm CET. More to come here 7:07 AM Oct 21st from web
- New Novartis Phase II study results announced for treatment of patients with chronic gout 4:58 AM Oct 20th from Seesmic
- Novartis committed to therapies for multiple sclerosis community 9:20 PM Oct 19th from web
- RT @ You’ve heard of Text to Give - but how about Text to Live? 2:11 PM Oct 14th from web
- CHMP positive opinion for QAB149 in patients with COPD, a life-threatening respiratory disease 9:17 AM Sep 25th from web
- Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren 12:52 AM Sep 18th from web
|
- Name Novartis
- Location Switzerland
- Web http://novartis.com
- Bio Latest Novartis news and updates from Novartis Communications
|